GLP1R and myocardial infarction: However, decreased mitral valve E/A ratio and increased E wave deceleration rate post-MI, which are reliable indicators of diastolic dysfunction (reflecting reduced LV filling and compliance, respectively) were both attenuated by GLP-1(9–36) treatment (Fig. 2e–f).